Shots:Anivive secured a $20M investment from Leonid to advance research of its programs, expand manufacturing, & support the marketing of its valley fever vaccine for canines
Funding follows a $33M NIAID contract with NIH to develop human vaccine for the fungus Coccidioides, which causes Valley fever, leading to ~$80M in preorders & contracts…
Shots: A California-based venture capital fund, Samsara Biocapital partners with medical companies and scientists to infuse cutting-edge innovations in medicines In 2023, Samsara participated in five funding rounds and invested around $2.3B to add 19 companies to its portfolio For a curated report on a specific investor or venture capital, reach out to us at connect@pharmashots.com …
Shots:Google Ventures is an investment arm of Alphabet Inc. That invests profusely in seed-stage companies ranging from software and internet to healthcare, life sciences, and artificial intelligence among othersEver since 2016, GV pivoted to focusing on established companies. The company manages assets worth $10B and 400 active portfolio companies spanning across North America…
Shots: RNAi therapeutics are innovative medications that enable rapid identification of specific inhibitors of disease targets across a wide range of molecule classes. Several biopharma companies are investing in RNAi therapeutics extravagantly to maintain a healthy foothold in innovative medicines In 2023, the global RNAi drug delivery market size was valued at $84.1B and is…
Shots:An ideal resort for tech-based startups, life science companies, and venture capital firms, Silicon Valley bank was the 16th largest bank in the United States. On March 17th, 2023, the bank’s former parent company, SVB’s Financial Group, filed for Chapter 11 bankruptcy Over the years, Silicon Valley Bank has supported numerous young businesses and…
